ROOT Act of 2018

Bill: 115-hr-5719
Sponsor: full_name: Rep. Black, Diane [R-TN-6]
Introduced: 2018-05-09
Policy area: Health
Subjects: Alternative treatments

Consumer affairs

Drug trafficking and controlled substances

Government information and archives

Health care quality

Health information and medical records

Health personnel

Hospital care

Medicare
Latest action: action_date: 2018-05-22
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2018-05-09
action_desc: Introduced in House
text: <p><b>Reduce Overprescribing Opioids in Treatment Act of 2018 or the ROOT Act of 2018</b></p> <p>This bill prohibits inclusion of pain management questions in a&nbsp;specified health care system survey used by the Centers for Medicare &amp; Medicaid Services, unless the questions address the risks of opioid use and the availability of non-opioid alternatives. </p>

tv_txt: I 115th CONGRESS 2d Session H. R. 5719 IN THE HOUSE OF REPRESENTATIVES May 9, 2018 Mrs. Black (for herself and Mr. O'Halleran ) introduced the following bill; which was referred to the Committee on Ways and Means A BILL To amend title XVIII of the Social Security Act to revise certain measures used under the Hospital Consumer Assessment of Healthcare Providers and Systems survey relating to pain management.

1. Short title This Act may be cited as the Reduce Overprescribing Opioids in Treatment Act of 2018 or the ROOT Act of 2018 . 2. Revising measures used under the Hospital Consumer Assessment of Healthcare Providers and Systems survey relating to pain management Section 1886(b)(3)(B)(viii) of the Social Security Act ( 42 U.S.C. 1395ww(b)(3)(B)(viii) ) is amended by adding at the end the following new subclause: (XII) With respect to the Hospital Consumer Assessment of Healthcare Providers and Systems survey (or a successor survey), beginning not later than January 1, 2020, such survey may not include questions about communication by hospital staff with an individual about such individual’s pain unless such questions take into account, as applicable, whether an individual experiencing pain was informed about risks associated with the use of opioids and about non-opioid alternatives for the treatment of pain. .